Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.

The overall average breast cancer incidence rate in the U.S. was 131.8 per 100,000 and the overall average breast cancer mortality rate was 19.3 per 100,000. Among women in the U.S., breast cancer ...

In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine ...

Artificial Intelligence can improve breast cancer detection and reduce workload on physicians, according to a new study from Germany featuring over 461,000 women.

Cancer diagnoses are shifting from older to younger adults and from men to women, according to a report released Thursday by ...

Data has revealed that British women under 50 are approximately 70% more likely to develop cancer than men of the same age, ...

Patients with HER-2 positive early breast cancer with residual invasive disease after neoadjuvant therapy were randomly ...

The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) has reached its enrollment goal of 108,508 women, as announced ...

Cancer deaths overall are falling, but the burden is shifting toward younger adults and women, the American Cancer Society ...

The Journal Sentinel reached out for comment but did not hear ... That's where the alcohol is," Loy said. "And the breast ...